Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

135.11
Delayed Data
As of Feb 16
 +1.76 / +1.32%
Today’s Change
13.09
Today|||52-Week Range
154.75
+47.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization516.0K673.0K662.0K156.00
 
 
 
 
 
 
Operating ExpensesGross Income-516.0K-673.0K-662.0K-156.00
 
 
 
 
 
General Expenses87.0M83.3M66.9M25.0M
 
 
 
 
 
Research And Development71.9M68.2M54.2M15.9M
 
 
 
 
 
Total Operating Expenses87.6M84.0M67.6M25.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-87.6M-84.0M-67.6M-25.0M
 
 
 
 
 
Extraordinary Charge0.00--0.00-242.0K
 
 
Interest Expense On Debt2.6M2.2M1.1M1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-90.2M-86.2M-68.7M-26.4M
 
 
 
 
 
Net Income-90.2M-86.2M-68.7M-26.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.0M2.8M3.7M5.2M
 
 
 
 
 
Shares To Calculate EPS Diluted2.0M2.8M3.7M5.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$44.45-$30.45-$18.55-$5.07
 
 
 
 
 
EPS Diluted-$44.45-$30.45-$18.55-$5.07